Key result
Morphine for AMI chest pain lacks rigorous evidence and risks delaying antiplatelet action.
Why the study?
Clinical practice guidelines strongly recommend morphine for analgesia in AMI patients despite the absence of rigorous studies assessing its impact and potential side effects.
Does morphine administration safely relieve chest pain in patients with acute myocardial infarction?
Population
Patients with acute myocardial infarction
Comparison
Morphine administration for analgesia vs no morphine
Design
Review
Authors
Loading...
Questions guideline-endorsed morphine use in AMI; leaves open optimal analgesia strategies for prospective trials.
Does morphine administration safely relieve chest pain in patients with acute myocardial infarction?
Morphine administration for chest pain in AMI, though recommended by guidelines, is associated with significant side effects including delayed onset of antiplatelet agents.
Guido Parodi (2015) conducted a review in Acute myocardial infarction (AMI). Morphine was evaluated. Morphine administration for chest pain in acute myocardial infarction lacks rigorous study and carries risks of hypotension, respiratory depression, vomiting, and delayed antiplatelet action.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: